摘要 |
<p>Peptide antigens which are immunoreactive with sera from individuals infected with hepatitis C virus (HCV) are disclosed. Several of the antigens are immunologically reactive with antibodies present in individuals identified as having chronic and acute HCV infection. The antigens are useful in generating antibodies for use in antigen-inhibition immunodiagnostic methods for detecting the presence of HCV antigens in test samples. The antigens are useful in diagnostic methods for detecting HCV infection in humans and for vaccine development.</p> |